newsfilter
← Latest News
Business Wire·

Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence

Supports Genmab's ambition to build an AI-enabled innovation model that advances the company's vision of bringing transformative antibody medicines to patients Genmab A/S (NASDAQ:GMAB) announced today a partnership